Tag Archives: Foghorn Therapeutics Inc.

Top Stories for Week of October 26, 2020

      No Comments on Top Stories for Week of October 26, 2020

Gilead’s remdesivir first to gain FDA approval for COVID-19 patients. The US Food and Drug Administration approved remdesivir (Veklury) on Thursday for treating hospitalized COVID-19 patients, a first for the disease that… Read more »

Top Stories for Week of October 5, 2020

      No Comments on Top Stories for Week of October 5, 2020

Trump hospitalized with COVID-19 diagnosis; doctors add steroid used in treating more severe patients. As most of the world is now aware, President Donald Trump was hospitalized Friday evening after… Read more »